Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. senior Avg
|
New words:
adenocarcinoma, adult, analogue, antigen, antineoplastic, anxiety, appealing, appetite, approach, baseline, bearing, Bellevue, CAPOX, carcinoma, chemo, condrituzumab, Davidson, dermatologic, dermatology, died, Diego, dimension, discomfort, double, encouraged, evidenced, exploratory, Gaza, glypican, HCC, hepatocellular, HRQoL, Immunotherapy, intravenously, iodine, irrevocable, Israel, Issuer, jointly, kg, mAb, mobility, moderate, molecule, Nancy, nausea, North, oncofetal, ophthalmic, ORR, pain, perpetual, PFS, poster, PTA, questionnaire, QW, radiolabeled, reaction, sample, San, sequence, SITC, situ, slight, Strip, surface, tissue, TRAE, TriTCE, uniformly, Unregistered, untreated, VAS, visual, zoster
Removed:
appointed, ASCO, autoimmune, concept, CPRA, Josephson, Neil, proof, reached, recently, space
Filing tables
Filing exhibits
Related press release
Associated Zymeworks transcripts
Zymeworks similar filings
Filing view
External links